The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage

Medicinal Research Reviews

Volumn 34, Issue 3, 2014, Pages 503-531

  Mondello, Stefania ^a   Schmid, Kara ^b   Berger, Rachel P ^c   Kobeissy, Firas ^d   Italiano, Domenico ^e   Jeromin, Andreas ^f   Hayes, Ronal L ^g   Tortella, Frank C ^b   Buki, Andras ^h,i  

^a UNIVERSITY OF MESSINA   (Italy)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MESSINA   (Italy)

^f NextGen Sciences Dx   (United States)

^g BANYAN BIOMARKERS INC   (United States)

^h UNIVERSITY OF PÉCS   (Hungary)

ⁱ INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Biomarkers; Concussion; Diagnostic; Mild TBI; Traumatic brain injury

Indexed keywords

BIOCHEMICAL MARKER;

ARTICLE; BATTLE INJURY; BRAIN CONCUSSION; BRAIN DAMAGE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; INCIDENCE; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PROTEOMICS; SPORT INJURY; TRAUMATIC BRAIN INJURY;

BIOMARKERS; CONCUSSION; DIAGNOSTIC; MILD TBI; TRAUMATIC BRAIN INJURY;

ATHLETIC INJURIES; BIOLOGICAL MARKERS; BRAIN CONCUSSION; BRAIN INJURIES; DECISION MAKING; HUMANS;

EID: 84897456880     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.21295     Document Type: Article

References (161)

1. Alexander MP. Mild traumatic brain injury-Pathophysiology, natural-history, and clinical management. Neurology 1995;45(7):1253-1260.
2. Abelson-Mitchell N. Epidemiology and prevention of head injuries: Literature review. J Clin Nurs 2008;17(1):46-57.
3. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: A brief overview. J Head Trauma Rehabil 2006;21(5):375-378.
4. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007;68(5):326-337.
5. Williamson IJ, Goodman D. Converging evidence for the under-reporting of concussions in youth ice hockey. Br J Sports Med 2006;40(2):128-132; discussion 128-132.
6. McCrea M, Hammeke T, Olsen G, Leo P, Guskiewicz K. Unreported concussion in high school football players-Implications for prevention. Clin J Sport Med 2004;14(1):13-17.
7. US Department of Defense. DoD Report to Congress on Expenditures for Activities on Traumatic Brain Injury and Psychological Health, Including Posttraumatic Stress Disorder for 2010. Ref ID: F-28E9BAD 2011.
8. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med 2008;358(5):453-463.
9. Menon DK, Schwab K, Wright DW, Maas AI, Demographics, Clinical Assessment Working Group of the I, Interagency Initiative toward Common Data Elements for Research on Traumatic Brain I, Psychological H. Position statement: Definition of traumatic brain injury. Arch Phys Med Rehabil 2010;91(11):1637-1640.
10. Ruff RM, Iverson GL, Barth JT, Bush SS, Broshek DK. Recommendations for diagnosing a mild traumatic brain injury: A National Academy of Neuropsychology Education Paper. Arc Clin Neuropsychol 2009;24(1):3-10.
11. Carroll LJ, Cassidy JD, Holm L, Kraus J, Coronado VG, Injury WHOCCTFoMTB. Methodological issues and research recommendations for mild traumatic brain injury: The WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med 2004;36(43 Suppl):113-125.
12. Heltemes KJ, Holbrook TL, Macgregor AJ, Galarneau MR. Blast-related mild traumatic brain injury is associated with a decline in self-rated health amongst US military personnel. Injury 2012;43(12):1990-1995.
13. Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry 2009;166(6):653-661.
14. Saatman KE, Duhaime A-C, Bullock R, Maas AIR, Valadka A, Manley GT, Workshop Sci Team Advisory P. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008;25(7):719-738.
15. The changing landscape of traumatic brain injury research. Lancet Neurol 2012;11(8):651.
16. Mac Donald CL, Johnson AM, Cooper D, Nelson EC, Werner NJ, Shimony JS, Snyder AZ, Raichle ME, Witherow JR, Fang R, Flaherty SF, Brody DL. Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med 2011;364(22):2091-2100.
17. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2(7872):81-84.
18. Green SM. Cheerio, laddie! Bidding farewell to the Glasgow Coma Scale. Ann Emerg Med 2011;58(5):427-430.
19. Haydel MJ, Preston CA, Mills TJ, Luber S, Blaudeau E, DeBlieux PMC. Indications for computed tomography in patients with minor head injury. N Engl J Med 2000;343(2):100-105.
20. Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, McKnight RD, Verbeek R, Brison R, Cass D, Eisenhauer MA, Greenberg GH, Worthington J. The Canadian CT head rule for patients with minor head injury. Lancet 2001;357(9266):1391-1396.
21. Smits M, Dippel DW, de Haan GG, Dekker HM, Vos PE, Kool DR, Nederkoorn PJ, Hofman PA, Twijnstra A, Tanghe HL, Hunink MG. Minor head injury: Guidelines for the use of CT-A multicenter validation study. Radiology 2007;245(3):831-838.
22. Yates DW. The NICE head injury guidelines. Emerg Med J 2003;20(2):117.
23. Stiell IG, Clement CM, Rowe BH, Schull MJ, Brison R, Cass D, Eisenhauer MA, McKnight RD, Bandiera G, Holroyd B, Lee JS, Dreyer J, Worthington JR, Reardon M, Greenberg G, Lesiuk H, MacPhail L, Wells GA. Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injury. J Am Med Assoc 2005;294(12):1511-1518.
24. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW, Parker L, de Gonzalez AB. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: A retrospective cohort study. Lancet 2012;380(9840):499-505.
25. Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann S, Williams AE. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. J Am Med Assoc 2012;307(22):2400-2409.
26. Vos PE, Alekseenko Y, Battistin L, Ehler E, Gerstenbrand F, Muresanu DF, Potapov A, Stepan CA, Traubner P, Vecsei L, von Wild K, European Federation of Neurological S. Mild traumatic brain injury. Eur J Neurol 2012;19(2):191-198.
27. Smits M, Dippel DW, Nederkoorn PJ, Dekker HM, Vos PE, Kool DR, van Rijssel DA, Hofman PA, Twijnstra A, Tanghe HL, Hunink MG. Minor head injury: CT-based strategies for management-A cost-effectiveness analysis. Radiology 2010;254(2):532-540.
28. Yuh EL, Mukherjee P, Lingsma HF, Yue JK, Ferguson AR, Gordon WA, Valadka AB, Schnyer DM, Okonkwo DO, Maas AI, Manley GT, the T-TBII. Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol 2013;73(2):224-235.
29. Lee H, Wintermark M, Gean AD, Ghajar J, Manley GT, Mukherjee P. Focal lesions in acute mild traumatic brain injury and neurocognitive outcome: CT versus 3T MRI. J Neurotrauma 2008;25(9):1049-1056.
30. Shimony JS, McKinstry RC, Akbudak E, Aronovitz JA, Snyder AZ, Lori NF, Cull TS, Conturo TE. Quantitative diffusion-tensor anisotropy brain MR imaging: Normative human data and anatomic analysis. Radiology 1999;212:770-784.
31. Conturo TE, McKinstry RC, Akbudak E, Robinson BH. Encoding of anisotropic diffusion with tetrahedral gradients: A general mathematical diffusion formalism and experimental results. Magn Reson Med 1996;35:399-412.
32. Mac Donald CL, Dikranian K, Song SK, Bayly PV, Holtzman DM, Brody DL. Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury. Exp Neurol 2007;205(2007):116-131.
33. Kou Z, Shen Y, Zakaria N, Kallakuri S, Cavanaugh JM, Yu Y, Hu J, Haacke EM. Correlation of fractional anisotropy with histology for diffuse axonal injury in a rat model. Joint Annual Meeting ISMRM-ESMRMB 2007, Berlin, Germany.
34. Ptak T, Sheridan RL, Rhea JT, Gervasini AA, Yun JH, Curran MA, Borszuk P, Petrovick L, Novelline RA. Cerebral fractional anisotropy score in trauma patients: A new indicator of white matter injury after trauma. Am J Roentgenol 2003;181:1401-1407.
35. Huisman TA, Schwamm LH, Schaefer PW, Koroshetz WJ, Shetty-Alva N, Ozsunar Y, Wu O, Sorenson AG. Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. Am J Neuroradiol 2004;25:370-376.
36. Arfanakis K, Haughton VM, Carew JD, Rogers BP, Dempsey RJ, Meyerand ME. Diffusion tensor MR imaging in diffuse axonal injury. Am J Neuroradiol 2002;23:794-802.
37. Inglese M, Makani S, Johnson G, Cohen BA, Silver JA, Gonen O, Grossman RI. Diffuse axonal injury in mild traumatic brain injury: A diffusion tensor imaging study. J Neurosurg 2005;103:298-303.
38. Benson RR, Meda SA, Vasudevan S, Kou Z, Govindarajan KA, Hanks RA, Millis SR, Makki M, Latif Z, Coplin W, Meythaler J, Haacke EM. Global white matter analysis of diffusion tensor images is predictive of injury severity in TBI. J Neurotrauma 2007;24(3):446-459.
39. Kou Z, Benson RR, Haacke EM. Susceptibility weighted imaging in traumatic brain injury. In: Gillard J, Waldman A, Barker P, Eds. Clinical MR Neuroimaging, 2nd ed. Cambridge: Cambridge University Press; 2010.
40. Paterakis K, Karantanas AH, Komnos A, Volikas Z. Outcome of patients with diffuse axonal injury: The significance and prognostic value of MRI in the acute phase. J Trauma 2000;49:1071-1075.
41. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272-277.
42. Toth A, Kovacs N, Perlaki G, Orsi G, Aradi M, Komaromy H, Ezer E, Bukovics P, Farkas O, Janszky J, Doczi T, Buki A, Schwarcz A. Multi-modal magnetic resonance imaging in the acute and sub-acute phase of mild traumatic brain injury: Can we see the difference? J Neurotrauma 2013;30(1):2-10.
43. Johnson B, Zhang K, Gay M, Horovitz S, Hallett M, Sebastianelli W, Slobounov S. Alteration of brain default network in subacute phase of injury in concussed individuals: Resting-state fMRI study. Neuroimage 2012;59(1):511-518.
44. Slobounov SM, Gay M, Zhang K, Johnson B, Pennell D, Sebastianelli W, Horovitz S, Hallett M. Alteration of brain functional network at rest and in response to YMCA physical stress test in concussed athletes: RsFMRI study. Neuroimage 2011;55(4):1716-1727.
45. Grossman EJ, Ge Y, Jensen JH, Babb JS, Miles L, Reaume J, Silver JM, Grossman RI, Inglese M. Thalamus and cognitive impairment in mild traumatic brain injury: A diffusional kurtosis imaging study. J Neurotrauma 2012;29(13):2318-2327.
46. Mayer AR, Mannell MV, Ling J, Gasparovic C, Yeo RA. Functional connectivity in mild traumatic brain injury. Hum Brain Mapp 2011;32(11):1825-1835.
47. Yuh EL, Cooper SR, Ferguson AR, Manley GT. Quantitative CT improves outcome prediction in acute traumatic brain injury. J Neurotrauma 2012;29(5):735-746.
48. Hughes DG, Jackson A, Mason DL, Berry E, Hollis S, Yates DW. Abnormalities on magnetic resonance imaging seen acutely following mild traumatic brain injury: Correlation with neuropsychological tests and delayed recovery. Neuroradiology 2004;46(7):550-558.
49. Wilson JTL, Wiedmann KD, Hadley DM, Condon B, Teasdale G, Brooks DN. Early and late magnetic-resonance imaging and neuropsychological outcome after head-injury. J Neurol Neurosurg Psychiatry 1988;51(3):391-396.
50. McCrory PR, Berkovic SF. Second impact syndrome. Neurology 1998;50(3):677->683.
51. Mondello S, Muller U, Jeromin A, Streeter J, Hayes RL, Wang KK. Blood-based diagnostics of traumatic brain injuries. Expert Rev Mol Diagn 2011;11(1):65-78.
52. Stern RA, Riley DO, Daneshvar DH, Nowinski CJ, Cantu RC, McKee AC. Long-term consequences of repetitive brain trauma: Chronic traumatic encephalopathy. PM R 2011;3(10 Suppl 2):S460-S467.
53. Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95.
54. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007;115(8):949-952.
55. Unden J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults? An evidence-based review and meta-analysis. J Head Trauma Rehabil 2010;25(4):228-240.
56. Kovesdi E, Luckl J, Bukovics P, Farkas O, Pal J, Czeiter E, Szellar D, Doczi T, Komoly S, Buki A. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 2010;152(1):1-17.
57. Vos PE, Jacobs B, Andriessen TMJC, Lamers KJB, Borm GF, Beems T, Edwards M, Rosmalen CF, Vissers JLM. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 2010;75(20):1786-1793.
58. Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, Wang KK, Hayes RL. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study. Crit Care 2011;15(3):R156.
59. Vos PE, van Gils M, Beems T, Zimmerman C, Verbeek MM. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol 2006;13(6):632-638.
60. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, Papa L, Brophy GM, Tortella F, Hayes RL, Wang KK. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 2012;70(3):666-675.
61. Brophy GM, Mondello S, Papa L, Robicsek SA, Gabrielli A, Tepas J, 3rd, Buki A, Robertson C, Tortella FC, Hayes RL, Wang KK. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma 2011;28(6):861-870.
62. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33(7):637-668.
63. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head-injury-A biochemical serum marker with prognostic value. J Neurol Neurosurg Psychiatry 1995;59(1):103-104.
64. de Boussard CN, Lundin A, Karlstedt D, Edman G, Bartfai A, Borg J. S100 and cognitive impairment after mild traumatic brain injury. J Rehabil Med 2005;37(1):53-57.
65. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Borgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Inj 2000;14(12):1047-1055.
66. Stapert S, de Kruijk J, Houx P, Menheere P, Twijnstra A, Jolles J. S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury. Eur Neurol 2005;53(1):22-26.
67. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma 1998;45(4):765-767.
68. Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. Eur J Neurol 2003;10(2):175-181.
69. Stalnacke BM, Ohlsson A, Tegner Y, Sojka P. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game. Br J Sports Med 2006;40(4):313-316.
70. Stranjalis G, Korfias S, Papapetrou C, Kouyialis A, Boviatsis E, Psachoulia C, Sakas DE. Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury. J Neurotrauma 2004;21(8):1070-1075.
71. Zongo D, Ribereau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, Montaudon D, Beaudeux JL, Meurin A, Dousset V, Loiseau H, Lagarde E. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 2012;59(3):209-218.
72. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, Hoecherl EFJ, Jonas F, Marzi I, Leucht P, Jochum M, Mutschler W. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury-A prospective multicenter study. Shock 2006;25(5):446-453.
73. Muller K, Townend W, Biasca N, Unden J, Waterloo K, Romner B, Ingebrigtsen T. S100B serum level predicts computed tomography findings after minor head injury. J Trauma 2007;62(6):1452-1456.
74. Routsi C, Stamataki E, Nanas S, Psachoulia C, Stathopoulos A, Koroneos A, Zervou M, Jullien G, Roussos C. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 2006;26(1):20-24.
75. Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G, Pirozzi N, Tufano R. S100B is not a reliable prognostic index in paediatric TBI. Pediatr Neurosurg 2007;43(4):258-264.
76. Berger RP, Dulani T, Adelson PD, Leventhal JM, Richichi R, Kochanek PM. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: A possible screening tool. Pediatrics 2006;117(2):325-332.
77. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ. Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 1996;10(5):471-476.
78. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir 1997;139(12):1161-1164.
79. de Kruijk JR, Leffers P, Menheere P, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients-A comparison with healthy controls. Acta Neurol Scand 2001;103(3):175-179.
80. Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, Rhind S, Tien HC, Baker AJ. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J Trauma 2011;71(5 Suppl 1):S478-S486.
81. Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, Albrecht M, Redl H, Bahrami S. Nonspecific increase of systemic neuron-specific enolase after trauma: Clinical and experimental findings. Shock 2005;24(2):119-123.
82. Pelinka LE, Jafarmadar M, Redl H, Bahrami S. Neuron-specific-enolase is increased in plasma after hemorrhagic shock and after bilateral femur fracture without traumatic brain injury in the rat. Shock 2004;22(1):88-91.
83. Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir 2005;60(6):477-480.
84. Cooper EH. Neuron-specific enolase. Int J Biol Markers 1994;9(4):205-210.
85. Zemlan FP, Rosenberg WS, Luebbe PA, Campbell TA, Dean GE, Weiner NE, Cohen JA, Rudick RA, Woo D. Quantification of axonal damage in traumatic brain injury: Affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem 1999;72(2):741-750.
86. Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, Zuccarello M. C-tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial pressure and clinical outcome. Brain Res 2002;947(1):131-139.
87. Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj 2006;20(7):759-765.
88. Bulut M, Koksal O, Dogan S, Bolca N, Ozguc H, Korfali E, Ilcoll YO, Parlak M. Tau protein as a serum marker of brain damage in mild traumatic brain injury: Preliminary results. Adv Ther 2006;23(1):12-22.
89. Ma M, Lindsell CJ, Rosenberry CM, Shaw GJ, Zemlan FP. Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury. Am J Emerg Med 2008;26(7):763-768.
90. Kavalci C, Pekdemir M, Durukan P, Ilhan N, Yidiz M, Serhatlioglu S, Seckin D. The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. Am J Emerg Med 2007;25(4):391-395.
91. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res 1971;28(2):351-354.
92. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H. Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results. Clin Chem 1999;45(1):138-141.
93. Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 2001;15(4):388-400.
94. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62(8):1303-1310.
95. Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M, Rosmalen CF, Vissers JL. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 2010;75(20):1786-1793.
96. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. J Neurotrauma 2004;21(11):1553-1561.
97. Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, Brophy GM, Demery JA, Dixit NK, Ferguson I, Liu MC, Mo J, Akinyi L, Schmid K, Mondello S, Robertson CS, Tortella FC, Hayes RL, Wang KK. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med 2012;59(6):471-483.
98. Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78(18):1428-1433.
99. Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport 1999;10(2):427-429.
100. Larsen CN, Price JS, Wilkinson KD. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: Identification of two active site residues. Biochemistry 1996;35(21):6735-6744.
101. Kobeissy FH, Ottens AK, Zhang Z, Liu MC, Denslow ND, Dave JR, Tortella FC, Hayes RL, Wang KKW. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics 2006;5(10):1887-1898.
102. Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, Demery JA, Liu MC, Mo J, Akinyi L, Mondello S, Schmid K, Robertson CS, Tortella FC, Hayes RL, Wang KK. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg 2012;72(5):1335-1344.
103. Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, Barzo P, Schmid K, Tortella F, Wang KK, Hayes RL. Glial neuronal ratio: A novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma 2012;29(6):1096-1104.
104. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F, Force ET. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006;13(9):913-922.
105. Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra TD, Ling G, Ottens AK, Tortella F, Hayes RL. Common data elements for traumatic brain injury: Recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil 91(11):1667-1672.
106. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009;73(22):1914-1922.
107. Hallen M, Karlsson M, Carlhed R, Hallgren T, Bergenheim M. S-100B in serum and urine after traumatic head injury in children. J Trauma 2010;69(2):284-289.
108. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RSB, Ruppel RA, Kochanek PM. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002;109(2):E31.
109. Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M. S-100 beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 2003;31(3):939-945.
110. Berger RP, Ta'Asan S, Rand A, Lokshin A, Kochanek P. Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatr Res 2009;65(1):97-102.
111. Geyer C, Ulrich A, Graefe G, Stach B, Till H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J Neurosurg Pediatr 2009;4(4):339-344.
112. Brenner DJ, Elliston CD, Hall EJ, Berdon WE. Estimates of the cancer risks from pediatric CT radiation are not merely theoretical: Comment on "point/counterpoint: in x-ray computed tomography, technique factors should be selected appropriate to patient size. against the proposition." Med Phys 2001;28(11):2387-2388.
113. Kirpalani H, Nahmias C. Radiation risk to children from computed tomography. Pediatrics 2008;121(2):449-450.
114. Brody AS, Frush DP, Huda W, Brent RL, American Academy of Pediatrics Section on R. Radiation risk to children from computed tomography. Pediatrics 2007;120(3):677-682.
115. Castellani C, Bimbashi P, Ruttenstock E, Sacherer P, Stojakovic T, Weinberg AM. Neuroprotein S-100B-A useful parameter in paediatric patients with mild traumatic brain injury? Acta Paediatr 2009;98(10):1607-1612.
116. Bechtel K, Frasure S, Marshall C, Dziura J, Simpson C. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics 2009;124(4):E697-E704.
117. Fridriksson T, Kini N, Walsh-Kelly C, Hennes H. Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: A pilot study. Acad Emerg Med 2000;7(7):816-820.
118. Bouvier D, Fournier M, Dauphin JB, Amat F, Ughetto S, Labbe A, Sapin V. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clin Chem 2012;58(7):1116-1122.
119. Scarfo GB, Mariottini A, Tomaccini D, Palma L. Growing skull fractures: Progressive evolution of brain damage and effectiveness of surgical treatment. Childs Nerv Syst 1989;5(3):163-167.
120. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 2007;24(12):1793-1801.
121. Beers SR, Berger RP, Adelson PD. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J Neurotrauma 2007;24(1):97-105.
122. Bandyopadhyay S, Hennes H, Gorelick MH, Wells RG, Walsh-Kelly CM. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad Emerg Med 2005;12(8):732-738.
123. Berger R, Richichi R. Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum. Pediatr Crit Care Med 2009;10(2):260-263.
124. Risdall JE, Menon DK. Traumatic brain injury. Philos Trans R Soc Lond B Biol Sci 2011;366(1562):241-250.
125. Wojcik BE, Stein CR, Bagg K, Humphrey RJ, Orosco J. Traumatic brain injury hospitalizations of U.S. army soldiers deployed to Afghanistan and Iraq. Am J Prev Med 2010;38(1 Suppl):S108-S116.
126. Tanielian TaLHJ, editor. Invisible Wounds of War. Santa Monica, CA: RAND Corporation; 2008.
127. Rigg JL, Mooney SR. Concussions and the military: Issues specific to service members. PM R 2011;3(10 Suppl 2):S380-S386.
128. Meyer KS, Marion DW, Coronel H, Jaffee MS. Combat-related traumatic brain injury and its implications to military healthcare. Psychiatr Clin North Am 2010;33(4):783-796.
129. Coldren RL, Kelly MP, Parish RV, Dretsch M, Russell ML. Evaluation of the Military Acute Concussion Evaluation for use in combat operations more than 12 hours after injury. Mil Med 2010;175(7):477-481.
130. Wang KK, Tate C, Hayes RL, Carr W, Kamimori GH. Blood-based brain injury biomarker analysis of The New Zealand Breacher Phase 1 Study. ATACCC 2010.
131. Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, Upreti C, Kracht JM, Ericsson M, Wojnarowicz MW, Goletiani CJ, Maglakelidze GM, Casey N, Moncaster JA, Minaeva O, Moir RD, Nowinski CJ, Stern RA, Cantu RC, Geiling J, Blusztajn JK, Wolozin BL, Ikezu T, Stein TD, Budson AE, Kowall NW, Chargin D, Sharon A, Saman S, Hall GF, Moss WC, Cleveland RO, Tanzi RE, Stanton PK, McKee AC. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 2012;4(134):134ra160.
132. Owens BD, Kragh JF, Jr., Wenke JC, Macaitis J, Wade CE, Holcomb JB. Combat wounds in operation Iraqi freedom and operation Enduring freedom. J Trauma 2008;64(2):295-299.
133. Kelly JF, Ritenour AE, McLaughlin DF, Bagg KA, Apodaca AN, Mallak CT, Pearse L, Lawnick MM, Champion HR, Holcomb JB. Injury severity and causes of death from operation Iraqi freedom and operation enduring freedom: 2003-2004 versus 2006. J Trauma 2008;64(2):S21-S26.
134. Schmid KE, Tortella FC. The diagnosis of traumatic brain injury on the battlefield. Front Neurol 2012;3:90.
135. Collins MW, Iverson GL, Lovell MR, McKeag DB, Norwig J, Maroon J. On-field predictors of neuropsychological and symptom deficit following sports-related concussion. Clin J Sport Med 2003;13(4):222-229.
136. Schulz MR, Marshall SW, Mueller FO, Yang JZ, Weaver NL, Kalsbeek WD, Bowling JM. Incidence and risk factors for concussion in high school athletes, North Carolina, 1996-1999. Am J Epidemiol 2004;160(10):937-944.
137. Gerberich SG, Priest JD, Boen JR, Straub CP, Maxwell RE. Concussion incidences and severity in secondary-school varsity football players. Am J Public Health 1983;73(12):1370-1375.
138. McCrory P. Should we treat concussion pharmacologically? Br J Sports Med 2002;36(1):3-5.
139. McCrory P, Meeuwisse W, Johnston K, Dvorak J, Aubry M, Molloy M, Cantu R. Consensus Statement on Concussion in Sport 3(rd) International Conference on Concussion in Sport Held in Zurich, November 2008. Clin J Sport Med 2009;19(3):185-200.
140. McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee H-S, Kubilus CA, Stern RA. Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009;68(7):709-735.
141. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Staining of amyloid precursor protein to study axonal damage in mild head-injury. Lancet 1994;344(8929):1055-1056.
142. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA. Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed-head injury. J Neurotrauma 1995;12(4):565-572.
143. Gorrie C, Oakes S, Duflou J, Blumbergs P, Waite PME. Axonal injury in children after motor vehicle crashes: Extent, distribution, and size of axonal swellings using beta-APP immunohistochemistry. J Neurotrauma 2002;19(10):1171-1182.
144. Jotwani V, Harmon KG. Postconcussion syndrome in athletes. Curr Sports Med Rep 2010;9(1):21-26.
145. Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Cantu RC, Randolph C, Jordan BD. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 2005;57(4):719-724.
146. Guskiewicz KM, McCrea M, Marshall SW, Cantu RC, Randolph C, Barr W, Onate JA, Kelly JP. Cumulative effects associated with recurrent concussion in collegiate football players-The NCAA Concussion Study. J Am Med Assoc 2003;290(19):2549-2555.
147. McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, Perl DP, Hedley-Whyte ET, Price B, Sullivan C, Morin P, Lee H-S, Kubilus CA, Daneshvar DH, Wulff M, Budson AE. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010;69(9):918-929.
148. Wetjen NM, Pichelmann MA, Atkinson JLD. Second impact syndrome: Concussion and second injury brain complications. J Am Coll Surg 2010;211(4):553-557.
149. Bazarian JJ, Blyth B, Cimpello L. Bench to bedside: Evidence for brain injury after concussion-Looking beyond the computed tomography scan. Acad Emerg Med 2006;13(2):199-214.
150. Unden J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults? An evidence-based review and meta-analysis. J Head Trauma Rehabil 2010;25(4):228-240.
151. de Kruijk JR, Leffers P, Manheere P, Meerhoff S, Rutten J, Twijnstra A. Prediction of post-traumatic complaints after mild traumatic brain injury: Early symptoms and biochemical markers. J Neurol Neurosurg Psychiatry 2002;73(6):727-732.
152. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: A role for protein S-100B? J Neurol Neurosurg Psychiatry 2002;73(5):542-546.
153. Waterloo K, Ingebrigtsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir 1997;139(1):26-31.
154. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999;45(3):468-475.
155. Otto M, Holthusen S, Bahn E, Sohnchen N, Wiltfang I, Geese R, Fischer A, Reimers CD. Boxing and running lead to a rise in serum levels of S-100B protein. Int J Sports Med 2000;21(8):551-555.
156. Hasselblatt M, Mooren FC, von Ahsen N, Keyvani K, Fromme A, Schwarze-Eicker K, Senner V, Paulus W. Serum S100 beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 2004;62(9):1634-1636.
157. Stalnacke BM, Tegner Y, Sojka P. Playing ice hockey and basketball increases serum levels of S-100B in elite players-A pilot study. Clin J Sport Med 2003;13(5):292-302.
158. Stalnacke BM, Tegner Y, Sojka P. Playing soccer increases serum concentrations of the biochemical markers of brain damage S-100B and neuron-specific enolase in elite players: A pilot study. Brain Inj 2004;18(9):899-909.
159. Stalnacke BM, Bjornstig U, Karlsson K, Sojka P. One-year follow-up of mild traumatic brain injury: Post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase. J Rehabil Med 2005;37(5):300-305.
160. Neselius S, Brisby H, Theodorsson A, Blennow K, Zetterberg H, Marcusson J. CSF-biomarkers in Olympic boxing: Diagnosis and effects of repetitive head trauma. PLoS One 2012;7(4):e33606.
161. Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 2010;48(12):1703-1711.